Coagulation reference ranges: Difference between revisions
Jump to navigation
Jump to search
m (Last reviewed) |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 27: | Line 27: | ||
|D DIMER | |D DIMER | ||
|ug/L | |ug/L | ||
|< 500 | |<50 yrs 500 | ||
51-60yrs 600 | |||
61-70yrs 700 | |||
71-80yrs 800 | |||
>80yrs 900 | |||
|N/A | |N/A | ||
|- | |- | ||
|FVIII | |FVIII | ||
|iu/dl | |iu/dl | ||
|50 - | |50 - 150 | ||
|N/A | |N/A | ||
|} | |} | ||
| Line 38: | Line 45: | ||
Reviewed | Reviewed August 2025 | ||
Latest revision as of 02:58, 7 November 2025
| Parameter | Units | Normal range | Therapeutic range |
| INR | Ratio | 0.8 - 1.2 | 2.0 - 3.0* |
| APTT | Seconds | 24-38 | 50 - 85 secs |
| FIBRINOGEN | g/L | 1.5-4.0 | N/A |
| TCT | Seconds | 15 - 21 | N/A |
| D DIMER | ug/L | <50 yrs 500
51-60yrs 600 61-70yrs 700 71-80yrs 800 >80yrs 900 |
N/A |
| FVIII | iu/dl | 50 - 150 | N/A |
*The INR therapeutic range may be higher for conditions such as heart valves, recurrent thromboembolism or arterial thromboembolism with associated antiphospholipid syndrome.
Reviewed August 2025